By: Ann Somers Hogg In our last report (“You Are What You Treat”), we identified the causal mechanisms inherent in traditional health care business models that perpetuate this challenge. Going one step further, this report addresses why most leaders fail to...
SpringTide was a major investor in PathologyWatch’s $3M seed round in early 2019, and took a board seat at that time. We continued to support the company through 2019, building the in-house sales force, and led PathologyWatch’s $5M Series A round in early 2020,...
Under the Microscope: PathologyWatch Cofounder April Larson Comes by Love of Health Care Naturally The business world is full of entrepreneurs from all fields putting a lot of blood, sweat, and tears into the success of their enterprises. Few of them, however, can...
Clinicians don’t need to take a blood, sweat, and tears sample to arrive at the diagnosis that clinician burnout is at an all-time high and health systems are struggling to provide the support and tools needed amid large financial losses. For healthcare innovators...
Guillaume Cohen-Skalli first became intrigued about finding a solution to the world’s under-the-radar hypothyroidism problem after watching a close friend struggle through multiple misdiagnoses of the disease—a struggle that lasted years. His friend met with five...
